Brought to you by:
One-year results from IVC stent clinical trial show positive safety and efficacy data
Twelve-month results from the clinical trial assessing a dedicated venous stent for the treatment of symptomatic inferior vena cava (IVC) obstruction with or without combined iliofemoral obstruction showed the device exceeded its performance goal for freedom from a composite of…
When are lymphedema pumps the answer?
The importance of activating the calf muscle pump in the treatment of lower extremity lymphedema came to the fore during the 2024 International Vein Congress (IVC) in Miami, Florida (April 18–20). “There are a whole host of non-proffered approaches you…
JVS-VL papers go under the microscope
On the final day of the 2024 International Vein Congress (April 18–20) in Miami, Florida, Joseph P. Hart, MD, associate professor of surgery and radiology at Medical College of Wisconsin in Milwaukee, Wisconsin, Andrea P. Munive-Gnecco, MD, from Bogotá, Colombia,…
Venous stenting and the IVC: ‘Persistent problems’ in the setting of post-thrombotic syndrome
The question of “persistent problems” with venous stenting among post-thrombotic syndrome (PTS) patients emerged as a key talking point during the recent Deep Venous Stenting Summit that took place during VAM 2023 in National Harbor, Maryland (June 14–17). The issue…
Study finds no correlation between IVC filter placement position and device complications
Researchers report that inferior vena cava (IVC) filter placement position relative to the level of the most inferior renal vein was not associated with differences in IVC thrombosis in a recent single-centre cohort study. Additional key findings from the study…
Correct coding for IVUS during venous and arterial interventions
The use of intravascular ultrasound (IVUS) can provide helpful information for assessment of pre- and post-intervention vascular status and, thus, is an important part of the management of patients with arterial and venous disease. IVUS can provide information about lesions not…
First US patient enrolled in Gore Viafort vascular stent pivotal study
W L Gore & Associates (Gore) has announced that the first U.S. patient has been enrolled in a prospective, randomized, multicenter, single-arm study with five-year follow-up to evaluate the investigational Gore Viafort vascular stent for the treatment of symptomatic inferior…
Gore completes first-in-human implants of Viafort vascular stent
W. L. Gore today announced the first implants of its investigational Gore Viafort vascular stent as part of a recently initiated pivotal clinical study for the treatment of inferior vena cava (IVC) occlusive disease with or without iliofemoral vein involvement. The…
Dedicated vs. non-dedicated: Researchers place venous stenting under the spotlight at AVF 2022
Venous stenting was a hot topic on the agenda of the recent American Venous Forum (AVF) annual meeting, held this year Feb. 23–26 in Orlando, Florida. Catching the audience’s attention, researchers highlighted a head-to-head study of dedicated versus non-dedicated stents, as…
‘Meet the Experts’ webinars now available OnDemand
Society for Vascular Surgery (SVS) members now have another chance to “Meet the Experts,” via computer screen and at no charge. Three of the “Meet the Experts” webinars held in spring and summer are now available on SVS OnDemand, part…